• About us
• Contact

Advertisement

Product › Details

Tyzeka™

	Next higher product group	telbivudine
	Status	2006-10-25 registration start
	Organisation	Novartis (Group)

Record changed: 2023-07-10

Advertisement

More documents for virostatic agent

• [1] CPTx GmbH. (9/12/24). "Press Release: CPTx Secures $29 Million to Advance Breakthrough Antiviral Platform". Planegg....
• [2] Marinomed Biotech AG. (8/14/24). "Press Release: Marinomed Biotech AG Aims for Financial Reorganization by Restructuring Proceedings without Self-administration". Korneuburg....
• [3] Bluejay Therapeutics. (5/9/24). "Press Release: Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline". San Mateo, CA....
• [4] ProBioGen AG. (3/13/24). "Press Release: ProBioGen Partners with Mapp Biopharmaceutical, Inc. for Groundbreaking Development of Afucosylated Antibody against Marburg Virus Disease Using GlymaxX Technology". Berlin....
• [5] Exscientia plc. (12/5/23). "Press Release: Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza". Oxford....
• [6] Memo Therapeutics AG. (11/16/23). "Press Release: Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer". Schlieren....
• [7] Memo Therapeutics AG. (11/02/23). "Press Release: Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients". Schlieren....
• [8] Abivax S.A.. (10/24/23). "Press Release: Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market". Paris....
• [9] Abivax S.A.. (10/20/23). "Press Release: Abivax Announces the Pricing of Its Initial Public Offering on the Nasdaq Global Market". Paris....
• [10] Abivax S.A.. (9/29/23). "Press Release: Abivax Files Registration Statement for Proposed Initial Public Offering in the United States". Paris....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.